{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6ompsLDA","lastupdate":"2024-11-18T00:00:00.000Z","update_date":"2024-11-18T00:00:00.000Z","lastModified":"Oct 30, 2025","active":1,"confidence_score":101,"confidence_score_reason":"markets","urlname":"nuvo","minimal_profile":null,"status":"Public","fullstatus":"Public on NASDAQ on May, 2024;","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$xnLAuhmmXBusBtOfoIhDGWOqyeTKz5BHC1d5qlaPRRaciz42mHHAxG","name":"Nuvo ","oneliner":"Remote Prenatal Monitoring Platform","registrar":"513849000","website":"https://www.nuvocares.com/home","careerspage":"","founded_month":6,"founded_year":2007,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/nuvocares","youtube":"","facebook":"https://www.facebook.com/nuvocares","linkedin":"https://www.linkedin.com/company/3145382","instagram":""},"social":["https://www.facebook.com/nuvocares","https://twitter.com/nuvocares","https://www.linkedin.com/company/3145382","https://apps.apple.com/il/app/invu-by-nuvo/id1524609104","https://play.google.com/store/apps/developer?id=Nuvo+Group"],"flattenedsociallinks":"https://www.facebook.com/nuvocares|https://twitter.com/nuvocares|https://www.linkedin.com/company/3145382|https://apps.apple.com/il/app/invu-by-nuvo/id1524609104|https://play.google.com/store/apps/developer?id=Nuvo+Group","apps":{"appstore":"https://apps.apple.com/il/app/invu-by-nuvo/id1524609104","googleplay":"https://play.google.com/store/apps/developer?id=Nuvo+Group"},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":48,"patent":1,"raised":58000000,"stage":"Public","public_stage":"Public","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Nuvo Care","Nuvo Group","Nuvo-Group","Nuvo Cares","Nuvo"],"about":"Nuvo is committed to reinventing pregnancy care through new technology, tools, and practices for providers and expectant mothers, including the INVU by Nuvo platform, an FDA-cleared, prescription initiated remote pregnancy monitoring and management system.\n\nINVU enables providers to conduct virtual well-being checks and remote non-stress-tests with expectant moms from anywhere, keeping patients and doctors connected at a time when it is needed most.\n","climatetech_description":null,"is_climatetech_relevant":null,"phone":"","country":null,"address":{"israeli":[{"id":"d3ee3198-6d68-4f18-98a4-cc8ee43b7032","city":"Tel Aviv-Yafo","type":null,"address":"Yigal Alon Street 94, Tel Aviv-Yafo, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"addff827-c35c-410a-ae47-3e8e80bd1a8f","city":"Princeton","address":"252 Nassau Street, Princeton, NJ, USA","country":"United States","placeid":null},{"id":"faf8b305-6bbd-4e20-8521-3d4e1931c7a4","city":"Kyiv","address":"Moskovska Street, 32/2, Kyiv, Ukraine","country":"Ukraine","placeid":null}]},"headquarter_address":null,"district":"Center District","news":[{"id":"IXoVmGN31j87RXpWWxLs1GoVqYwf6jQ8OqndDUfYdAyPGXIMLtLyCo","date":"Sep 5, 2024","link":"https://finance.yahoo.com/news/attention-direct-indirect-holders-securities-031300759.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"bankruptcy","company":"Holdco Nuvo Group D.G Ltd.","layoffs":null,"summary":"Holdco Nuvo Group D.G Ltd. has announced that the United States Bankruptcy Court for the District of Delaware has imposed significant restrictions on trading in the companys equity interests. This development is part of a bankruptcy case, with the case number 24-11880 (MFW). The order and further details can be accessed online, and inquiries can be directed to Epiq Corporate Restructuring, LLC or the proposed counsel for the debtors. This court order is expected to have a negative impact on the companys growth prospects.","partners":[],"customers":[],"investors":[],"confidence":10,"key_topics":["bankruptcy","court order","trading restrictions","equity interests","legal proceedings"],"date_of_event":"2024-09-04","valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Public Trading"],"acquisition_amount":null,"structuredIssuesShow":"#Public Trading","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"QSbhVgX5lniwhLeQIY2rUY8s4nsoK6HtyzrA7hnP8iam3tegjW8Ifp","news_summary":"ATTENTION DIRECT AND INDIRECT HOLDERS OF SECURITIES ISSUED BY HOLDCO NUVO GROUP D.G LTD.: The United States Bankruptcy Court for the District of Delaware has entered an order that imposes substantial restrictions on trading in equity interests in Holdco Nuvo Group D.G Ltd. and affiliates","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"zVXB0dcJvc019cUzSbJOZt7COWPMkTrwDoTtJmEZx5hD62uUA4BmQW","date":"May 9, 2024","link":"https://finance.yahoo.com/news/nuvo-group-adds-healthtech-veteran-123000186.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"board expansion","company":"Holdco Nuvo Group D.G Ltd","layoffs":null,"summary":"Holdco Nuvo Group D.G Ltd, a pioneer in remote pregnancy monitoring, announced the expansion of its board of directors with the addition of Adriana Machado. Machado brings extensive experience in business leadership, strategic planning, and international relations, and will help guide Nuvo’s mission of addressing health disparities and social determinants of care. Nuvo, which recently listed on NASDAQ, aims to expand its footprint in the US and Israel and plans to introduce its INVU platform in Europe in 2024. The company is focused on providing remote pregnancy monitoring and improving access to care for expectant mothers globally.","partners":[],"customers":[],"investors":[],"confidence":10,"key_topics":["NASDAQ listing","board expansion","health innovation","remote monitoring","international relations"],"date_of_event":"May 09, 2024","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ltSrsA3Dd1jzGEXxz4v6NGM0u2YsFIxb5c58kBk6SLEB4GUMNum4LM","news_summary":"Nuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company’s Commitment to Transforming Prenatal Care","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"53T0NqYPrNqxTUrhcAJMtUsGBcMVig5ZrPntmgVrOHPwtEDXkxTYSB","date":"May 2, 2024","link":"https://femtechinsider.com/nuvo-lamf-global-ventures-public/","source":"femtechinsider.com","visible":1,"analysis":{"tags":"Public Trading, Expansion","company":"Nuvo Group","layoffs":"Not mentioned","summary":"Nuvo Group, a company specializing in remote pregnancy monitoring, has completed its business combination with LAMF Global Ventures, transitioning into a publicly traded company on NASDAQ under the ticker symbol NUVO. The companys INVU platform, an FDA-cleared pregnancy monitoring and management system, uses wearable technology, AI, and machine learning to provide real-time insights into maternal and fetal health. The business combination will allow Nuvo to access capital markets to fuel commercial growth, international expansion, and expedite its innovation pipeline.","partners":"LAMF Global Ventures","customers":"Not mentioned","investors":"LAMF Global Ventures","confidence":9,"key_topics":["Public Listing","Remote Pregnancy Monitoring","Healthcare Technology","Expansion","Business Combination"],"date_of_event":"April 1, 2024","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Public Trading","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Public Trading  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"kXBDx45XBUQd6tg73U1miLPNIBxiRPkAREk3rGpUPVJ8eOf4OImxbt","news_summary":"Remote Pregnancy Monitoring Company Nuvo Goes Public Through Merger with LAMF Global Ventures - ","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"l9Jqqh9O9Xz2UJSgMzlGBfw4xTVl1zSV0nOxYl2DCMc6lfHV38KIRW","date":"May 1, 2024","link":"https://news.spacconference.com/2024/05/02/nuvo-group-completes-merger-with-lamf-global-ventures-i/","source":"news.spacconference.com","visible":1,"analysis":{"tags":"Business Combination, Pregnancy Care Technology","company":"Nuvo Group","layoffs":"Not mentioned","summary":"Nuvo Group, an Israel-based company that provides a pregnancy monitoring and management platform, has completed its business combination with LAMF Global Ventures I. As a result, Nuvo shares are now listed on the Nasdaq under the ticker symbol NUVO. The transaction was approved by LAMF’s shareholders on April 1, leaving $434,982 in cash in the trust account. The deal, announced last August, valued Nuvo at a pre-money equity valuation of $269 million, potentially rising to $300 million if Nuvo achieves certain commercial milestones.","partners":"LAMF Global Ventures I","customers":"Not mentioned","investors":"LAMF Global Ventures I","confidence":9,"key_topics":["Business Combination","Healthcare Technology","Pregnancy Monitoring","Public Trading","Partnership"],"date_of_event":"April 1","valuation_amount":"$269 million","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Public Trading","Partners"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Public Trading  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"PvcbXqNP7Ch7k1AmzpElGBi5N6tLxJprO7ZLJ3j5jeZf5aN09PJTgm","news_summary":"Nuvo Group Completes Merger with LAMF Global Ventures I | DealFlow's SPAC News","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"qRJjTeD9Q56SPE6wcB0qMgAX4ALrfkjuN5tzgOidGbUc9ULmKUTKsm","date":"Apr 1, 2024","link":"https://www.prnewswire.com/news-releases/lamf-global-ventures-corp-i-shareholders-approve-previously-announced-business-combination-with-nuvo-group-ltd-302106303.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Merger, Public Trading","company":"Nuvo Group Ltd., LAMF Global Ventures Corp. I","layoffs":"Not mentioned","summary":"Nuvo Group Ltd., a remote pregnancy monitoring platform, and LAMF Global Ventures Corp. I, a publicly traded special purpose acquisition company, have announced that LAMFs shareholders have voted to approve the previously announced business combination between the two companies. The combined company will operate as Holdco and is expected to be listed on Nasdaq under the ticker symbol NUVO. The transaction is expected to close as soon as practicable.","partners":"Not mentioned","customers":"Not mentioned","investors":"LAMF Global Ventures Corp. I","confidence":9,"key_topics":["Business Combination","Shareholder Approval","Redemption of Shares","Nasdaq Listing","Remote Pregnancy Monitoring"],"date_of_event":"April 1, 2024","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Acquired-by","Public Trading"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Acquired-by  #Public Trading","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"83n0C03qc40FBdgEQbis6ed5cugVkSTMJvg3xLMfnE7iIuPxIGgXa6","news_summary":"LAMF Global Ventures Corp. I Shareholders Approve Previously Announced Business Combination with Nuvo Group Ltd.","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"6RJqoWZ2XtrWfX4STfBWhtMGKQndk0YYQuBsAW9j0BSpYPZjoof0po","date":"Aug 17, 2022","link":"https://www.drugdeliverybusiness.com/nuvo-sheba-ai-gestational-diabetes-management/","source":"www.drugdeliverybusiness.com","visible":1,"analysis":{"tags":"Partnership, Telemedicine","company":"Nuvo Group","layoffs":"N/A","summary":"Nuvo Group has completed the first phase of a collaboration agreement with Sheba Medical Center’s “Sheba BEYOND.” The partnership focused on a pilot program for gestational diabetes management, shifting non-stress tests to home-based, remote monitoring using Nuvo’s INVU. The next phase of the partnership will integrate the INVU platform into the hospital’s standard of care protocols and utilize data from the pilot program to develop new AI tools to improve pregnancy care management.","partners":"Sheba Medical Center","customers":"Expectant mothers","investors":"N/A","confidence":9,"key_topics":["Collaboration","Gestational Diabetes Management","Remote Monitoring","Telemedicine","AI Tools"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Partners","Expand"],"acquisition_amount":"N/A","structuredIssuesShow":"#Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"YeIfpHX9b0u8emf2fichBUlxREffT5ynMW6LDnkDfzxV6ghxElRKnP","news_summary":"Nuvo, Sheba develop AI-powered gestational diabetes platform","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"csPHvGqSdxmKCr8yZbVZYNu9fLk0NOPpYvJjljQfgSm16DE4SQrD9n","date":"Feb 25, 2022","link":"https://www.mobihealthnews.com/news/philips-partners-nuvo-group-remote-pregnancy-monitoring-and-more-digital-health-briefs","source":"www.mobihealthnews.com","visible":1,"analysis":{"tags":"remote pregnancy monitoring","company":"Royal Philips","layoffs":null,"summary":"Royal Philips is partnering with Nuvo Group to support remote pregnancy monitoring in rural areas. The collaboration aims to improve access to maternity care in rural communities. Additionally, Pear Therapeutics digital therapeutics will be available in Epics App Orchard Gallery, allowing providers to monitor patients using the companys therapeutics within the EHR. AppliedVR, a virtual reality therapeutics startup, has changed the name of its therapeutic system to RelieVRx and appointed a new chief medical officer. The company plans to launch RelieVRx to treat chronic lower back pain.","partners":["Nuvo Group","Epic"],"customers":null,"investors":null,"confidence":8,"key_topics":["Remote pregnancy monitoring","Digital solutions","Maternal health care","Remote monitoring options","Prescription digital therapeutics"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"2W4c4sCGtVlhKpzwsqysBSiyF43TULIHvXwU8QaX8N4OCtREArT3nA","news_summary":"Philips partners with Nuvo Group for remote pregnancy monitoring and more digital health briefs","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"B7YVc4zh1diJ3fmBVfIMBYtVVZkkrHVN8FeoHP0UVpf7r8Uxjsl0Mv","date":"Jan 12, 2022","link":"https://www.prnewswire.com/news-releases/nuvo-group-and-unified-womens-healthcare-announce-strategic-collaboration-agreement-to-introduce-a-remote-pregnancy-monitoring-platform-across-affiliate-care-centers-301458470.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":["partnership"],"company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has entered into a collaboration agreement with Unified Womens Healthcare to pilot the use of its remote pregnancy monitoring platform, INVU, at Genesis OBGYN. The partnership aims to shift medically necessary tests to home-based, remote monitoring using INVU, allowing expectant mothers to wear the sensor band during virtual visits with their physicians. The collaboration will improve patient convenience, adherence to care protocols, and overall patient and provider experience. After the pilot, Unified and Nuvo intend to integrate the INVU platform into Unifieds network of medical affiliate care centers across the United States.","partners":["Unified Womens Healthcare"],"customers":null,"investors":null,"confidence":8,"key_topics":["remote pregnancy monitoring","collaboration agreement","virtual visits","improved patient and provider experience","expanding access to care"],"date_of_event":"2022-01-12","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Al9Fc432jNkbGYMZRh3YW5HPmL8rP1FguBMZpFJOkHoJTAxFDRfazH","news_summary":"Nuvo Group and Unified Women's Healthcare Announce Strategic Collaboration Agreement to Introduce a Remote Pregnancy Monitoring Platform Across Affiliate Care Centers","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"GgijSxu7sWncoUvNrtd0PMgseQJd3WlMLsywbqpLWs2Keq9yXENWuE","date":"Jan 5, 2022","link":"https://www.prnewswire.com/news-releases/nuvo-group-partners-with-charite--universitatsmedizin-berlin-to-establish-a-remote-fetal-surveillance-protocol-for-europe-and-study-predictive-analytics-on-preeclampsia-patients-301453674.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":["remote pregnancy monitoring","partnership","predictive analytics","health outcomes"],"company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has announced a partnership with Charité – Universitätsmedizin Berlin to bring remote pregnancy monitoring to Europe and explore the use of predictive analytics to improve health outcomes. The partnership aims to define a remote pregnancy care protocol for Germany and Europe, allowing expectant mothers to conduct remote fetal surveillance under the supervision of a physician. The trial also aims to identify predictive pathways for preeclamptic patients. Nuvo Groups INVU™ platform, an FDA-cleared remote pregnancy monitoring system, allows expectant mothers to monitor maternal-fetal health from anywhere. The partnership with Charité will evaluate the improvement of care with remote monitoring and explore the use of predictive algorithms for hypertensive pregnancy disorders. The partnership is expected to revolutionize the delivery of care and increase access to care for patients.","partners":["Charité – Universitätsmedizin Berlin"],"customers":null,"investors":null,"confidence":9,"key_topics":["remote pregnancy monitoring","predictive analytics","partnership","health outcomes","remote fetal surveillance"],"date_of_event":"2022-01-05","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"n9WMgR7Y9ZhJQJDDXNjgwcmaRWq15TKw7yptKBJvTBHQHl50lyaFhN","news_summary":"Nuvo Group Partners with Charité - Universitätsmedizin Berlin to Establish a Remote Fetal Surveillance Protocol for Europe and Study Predictive Analytics on Preeclampsia Patients","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ac84dac8-9f55-44aa-b222-76f9aa2eb82c","date":"Aug 9, 2021","link":"https://www.prnewswire.com/news-releases/nuvo-group-recruits-new-ceo-to-lead-next-stage-of-company-growth-301350518.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"appointment","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has appointed Kelly Londy as the new CEO, succeeding founder and former CEO Oren Oz. Oz will transition to the role of chief innovation officer. Londy brings significant healthcare experience and a track record of commercialization success to the company. Nuvo aims to revolutionize pregnancy care with its INVU platform, which combines hardware, software, and AI tools for remote pregnancy monitoring. The company has recently added industry leaders to its board of directors. Nuvo received FDA clearance for maternal and fetal heart rate monitoring in 2020 and a supplemental clearance for remote monitoring of uterine activity in May 2021.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["appointment","healthcare","commercialization","FDA clearance","innovation"],"date_of_event":"August 9, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"JCl99sayZmVvrVRVQJUNhLaBIa9PtQ5DO9x8VufGaGhIQfEmnyD8Yg","news_summary":"Nuvo Group Recruits New CEO to Lead Next Stage of Company Growth","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"34d0a006-7966-4351-be28-adb297ac3471","date":"Jun 10, 2021","link":"https://www.mobihealthnews.com/news/fda-greenlights-nuvo-groups-uterine-activity-module?utm_source=dlvr.it&utm_medium=linkedin","source":"www.mobihealthnews.com","visible":1,"analysis":{"tags":"remote pregnancy monitoring","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has received FDA clearance for a new uterine activity module for its INVU system, a remote pregnancy monitoring system. The clearance allows the device to be used for non-stress testing in pregnant individuals who are in their 32nd week of gestation or later. The addition of the uterine activity module provides an alternative to existing methods of measuring uterine activity that have limitations. Nuvo Groups INVU system offers a reliable solution for remote monitoring of fetal wellbeing, providing expectant mothers and healthcare providers with comprehensive care. The femtech market, including prenatal monitoring devices, is growing and expected to reach $1.15 billion by 2025.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["FDA clearance","remote pregnancy monitoring","uterine activity module","alternative methods","femtech market"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"9z0fncegUxt5QkmsJWAgG8uO6Rkq4Hlv8usNAOGMEJcmGgE89GfvRd","news_summary":"FDA greenlights Nuvo Group's uterine activity module","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"adb8c189-6e3e-4deb-87b5-50e71804e4bd","date":"Jun 2, 2021","link":"https://www.prnewswire.com/il/news-releases/nuvo-group-announces-appointment-of-joseph-devivo-to-board-of-directors-301303402.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"appointment","company":"Nuvo Group Ltd.","layoffs":null,"summary":"Joseph M. DeVivo has been appointed to the board of directors of Nuvo Group Ltd., a company commercializing INVU by Nuvo, a remote pregnancy monitoring platform. DeVivos appointment is expected to support Nuvos mission of improving health outcomes in pregnancy care through the use of data, analytics, and digital tools. DeVivo brings extensive healthcare leadership experience to Nuvo Group, having served in various roles in medical device and healthcare technology companies. His appointment is seen as valuable in optimizing Nuvos offering, accelerating adoption, and advancing maternal and fetal health. Nuvo Group is committed to advancing pregnancy care with new technology and practices through its INVU platform.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["appointment","pregnancy monitoring","digital health","telehealth","maternal and fetal health"],"date_of_event":"June 2, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"NwKrCAptxB0Cip9YFkCN1tRKPlkb87Yb1sxs0NCHpxgAKXojbHV2FI","news_summary":"Nuvo Group Announces Appointment of Joseph DeVivo to Board of Directors","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"907cd522-6c2b-473a-850a-464ede30a9f1","date":"May 15, 2021","link":"https://startup.info/oren-oz-nuvo/","source":"startup.info","visible":1,"analysis":{"tags":"remote pregnancy management","company":"Nuvo","layoffs":null,"summary":"The article features an interview with Oren Oz, the Founder and CEO of Nuvo, a remote pregnancy management platform. Oz discusses the challenges and adjustments brought by COVID-19, the inspiration behind starting Nuvo, and the companys innovation in transforming pregnancy care. Nuvos flagship offering, the INVU platform, has received FDA clearance for maternal and fetal heart rate monitoring and is working on remote monitoring of maternal uterine activity. The pandemic has positively impacted Nuvos business finances, as the demand for remote monitoring increased. The company has been able to hire employees and continue building on their offerings. Nuvos customer relationship management has evolved with a focus on virtual meetings and using technology to connect with users and clients. The article does not mention any specific customers or investors.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["COVID-19","Remote pregnancy monitoring","Telehealth","FDA clearance","Customer relations"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"HQ1R8ZEj3emHTijSCLGyWVw7yYfa0rVgcqvfku1n8JDUEqLS2HbtJ6","news_summary":"Oren Oz of Nuvo tells us about at-home pregnancy care","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"15425e98-3cbc-44c2-a5aa-e052a80bdbaa","date":"Mar 23, 2021","link":"https://www.prnewswire.com/news-releases/nuvo-group-partners-with-university-of-utahs-child-adaptation-and-neurodevelopment-can-lab-on-baby-affect-and-behavior-baby-study-301253265.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":["partnership","research"],"company":"Nuvo Group Ltd.","layoffs":null,"summary":"Nuvo Group has partnered with the University of Utahs Department of Psychology on a study to analyze the relationship between prenatal maternal distress and childrens health outcomes. The study, supported by a National Institute of Mental Health grant, will use Nuvos INVU platform to measure maternal and fetal heart rate variability. The research aims to predict the impact of the mothers emotional state during pregnancy on the childs health outcomes. INVUs remote capabilities allow study participants to measure heart rates from home, making it possible to continue the study during the COVID-19 pandemic. The full results of the study are expected in 2023.","partners":["University of Utahs Department of Psychology"],"customers":null,"investors":null,"confidence":9,"key_topics":["pregnancy monitoring","maternal distress","child health outcomes","heart rate variability","remote monitoring"],"date_of_event":"2021-03-23","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Y68GJi4krT8nAQXLpQpP8hI8QgjHatlYUW38LRrSglOvpeT58OXJRq","news_summary":"Nuvo Group Partners with University of Utah's Child Adaptation and Neurodevelopment (CAN) Lab on Baby Affect and Behavior (BABY) Study","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"2d7708aa-6b4d-42bd-a046-58f8c35233be","date":"Jan 13, 2021","link":"https://www.prnewswire.com/news-releases/nuvo-group-submits-510k-to-federal-drug-administration-for-remote-monitoring-of-maternal-uterine-activity-301207410.html?tc=eml_cleartime","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"remote pregnancy monitoring","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has filed a 510(k) notice with the FDA to add a new uterine activity module to its INVU platform for remote pregnancy monitoring. The module will enable providers to recognize uterine contractions in women being monitored at home, providing a non-invasive alternative to the current standard of care. The INVU platform has already received FDA clearance for remote monitoring of fetal and maternal heart rates. This expansion of the platform will provide expectant mothers and healthcare providers with more comprehensive data on maternal and fetal health. Nuvo Group is committed to advancing pregnancy care with new technology and tools.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["FDA clearance","remote monitoring","maternal uterine activity","pregnancy care","technology"],"date_of_event":"January 13, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"uXlIdiRhiLaNadZwQABev7r0uAeJLYowSCm3zlVpW1FHv2bixkvS1M","news_summary":"Nuvo Group Submits 510(k) to Federal Drug Administration for Remote Monitoring of Maternal Uterine Activity","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7458f06f-d03f-44d7-82f8-64eb578bf09f","date":"Jan 6, 2021","link":"https://www.prnewswire.com/news-releases/nuvo-group-forms-commercial-partnership-with-axia-womens-health-to-offer-the-first-invu-remote-pregnancy-monitoring-platform-301201946.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"partnership","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has entered into a commercial agreement with Axia Womens Health, a womens health network, to adopt the INVU remote pregnancy monitoring platform. Axia Womens Health will be the first healthcare provider in the United States to use the platform, which allows expectant mothers to wear a sensor band and have virtual visits with their physicians. The platform provides fetal and maternal heart rate tracings comparable to in-office checks. The agreement allows Axia Womens Health to shift a portion of scheduled appointments to virtual visits and perform remote fetal wellness checks. The partnership aims to advance maternal and fetal health through technology and tools. Nuvo Group sees this agreement as a milestone in transforming care delivery.","partners":"Axia Womens Health","customers":null,"investors":null,"confidence":9,"key_topics":["remote pregnancy monitoring","commercial agreement","Axia Womens Health","INVU platform","maternal and fetal health"],"date_of_event":"January 6, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"NRLJFVR4p9SKSKfBmeVhZ6uO0GBMWAqFObB85a6PxbS9ut9NS6Ow13","news_summary":"Nuvo Group Forms Commercial Partnership with Axia Women's Health to Offer the First INVU™ Remote Pregnancy Monitoring Platform","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d93d6138-80be-4ad5-9d67-18572ba0a426","date":"Sep 1, 2020","link":"https://www.prnewswire.com/news-releases/nuvo-group-announces-appointment-of-dr-stephen-k-klasko-to-board-of-directors-301121850.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"appointment","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has announced the appointment of Stephen K. Klasko, MD MBA, President of Thomas Jefferson University and Chief Executive Officer of Jefferson Health, to its Board of Directors. Dr. Klasko has been a member of Nuvos Strategic Advisory Board since 2019 and brings valuable experience in telehealth and healthcare innovation. Nuvo Group aims to revolutionize pregnancy care delivery and create value for all stakeholders. The company combines proprietary hardware, cloud-based software, and AI tools to optimize the pregnancy care experience. The INVU platform has received FDA clearance for maternal and fetal heart rate monitoring. The appointment of Dr. Klasko is expected to provide insights, strategic guidance, and market connections to support Nuvos growth in the 21st century.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["appointment","telehealth","pregnancy care","healthcare","technology"],"date_of_event":"August 31, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"zDlozQ7IsJlUCy2RvgBApiyZS2QFfvndZMGi5fOfCYvQduZeZcRaEw","news_summary":"Nuvo Group Announces Appointment of Dr. Stephen K. Klasko to Board of Directors","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"a5024096-a28a-4cfd-926d-edbd3af5bcdc","date":"Aug 13, 2020","link":"https://www.prnewswire.com/news-releases/nuvo-group-named-to-the-2020-cb-insights-digital-health-150----list-of-most-innovative-digital-health-startups-301111959.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":["digital health","healthcare","technology"],"company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has been named to CB Insights Digital Health 150 ranking, which showcases the most promising private digital health companies in the world. The ranking highlights startups that are reimagining the traditional healthcare experience. Nuvo Groups INVU platform, a remote pregnancy monitoring platform, has received clearance from the FDA for home use. The company has also announced a partnership with the Hadassah-Hebrew University Medical Center to create data-driven solutions for personalized pregnancy care. The Digital Health 150 startups have raised over $20 billion in funding and include 12 unicorns. Nuvo Group is committed to advancing pregnancy care with new technology and tools.","partners":["Hadassah-Hebrew University Medical Center"],"customers":null,"investors":null,"confidence":9,"key_topics":["Digital Health 150","remote pregnancy monitoring","partnerships","FDA clearance","healthcare technology"],"date_of_event":"August 13, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"tvSWnCS46CSGHv9682Aw3ecefoWrSfGEWrJLlQCBY1RzZJYCuN8kmm","news_summary":"Nuvo Group Named to the 2020 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"6cf1fabb-3006-46bd-967b-8ad95f976967","date":"Aug 6, 2020","link":"https://m-jpost-com.cdn.ampproject.org/c/s/m.jpost.com/opinion/hillels-tech-corner-pregnancy-care-done-right-637766/amp","source":"m-jpost-com.cdn.ampproject.org","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"zdykWAi1vECiECADBosRyC91exK1HlZ5Q6zqAIEcoZx6Xl0opuw8Ba","news_summary":"Hillel's Tech Corner: Pregnancy care done right","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"30f53865-e492-4473-8e6c-0f8353137d4f","date":"May 27, 2020","link":"https://www.wfmz.com/news/pr_newswire/pr_newswire_business/nuvo-group-to-present-at-the-jefferies-virtual-healthcare-conference/article_f163de6a-9892-55a0-932c-7a465d524c91.html","source":"www.wfmz.com","visible":1,"analysis":{"tags":"presentation, healthcare","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group will present at the 2020 Jefferies Virtual Healthcare Conference to provide a corporate overview for 2020, with a focus on their launch into the U.S. market. They are a private company commercializing INVU, a remote pregnancy monitoring platform. The conference is invitation-only, and interested viewers can access the live webcast through Jefferies website. Nuvo Group is committed to advancing pregnancy care with new technology and tools, and their INVU platform combines hardware and software solutions powered by AI tools. The company has received FDA clearance for maternal and fetal heart rate monitoring and is working towards clearance for remote monitoring of uterine activity.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["INVU platform","Jefferies Virtual Healthcare Conference","U.S. market launch","pregnancy monitoring","AI tools"],"date_of_event":"2020-06-03","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"sG0Lflf0xaDwHUd4EelfMs0QrnQ5bQyUocpKFkoZwzvA6jxuIByHOz","news_summary":"Nuvo Group to Present at the Jefferies Virtual Healthcare Conference","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"e3a6f6d5-08e4-4b49-b798-c6276907ba26","date":"May 13, 2020","link":"https://www.prnewswire.com/news-releases/nuvo-group-announces-partnership-with-hadassah-hebrew-university-medical-center-to-develop-innovative-pregnancy-population-management-platform-301058487.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"partnership","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has announced a collaborative partnership with the Hadassah-Hebrew University Medical Center to develop data-driven solutions for personalized pregnancy care. Under the agreement, Nuvo will have access to Hadassahs database of medical records to create clinical decision support systems integrated into their INVU platform. The partnership aims to improve patient outcomes, lower healthcare costs, and address the challenges in pregnancy care. Nuvo plans to expand into additional collaborations to develop a proprietary pregnancy population management solution. The partnership is seen as a strategic move for Nuvos future growth. The CEO of Nuvo Group believes that the integration of decision support tools based on unique data will offer value to providers and payers. The partnership has been well-received by the Head of the Division of Obstetrics and Gynecology at Hadassah-Hebrew University Medical Centers.","partners":["Hadassah-Hebrew University Medical Center"],"customers":null,"investors":null,"confidence":9,"key_topics":["pregnancy care","data-driven solutions","clinical decision support systems","personalized pregnancy care","healthcare costs"],"date_of_event":"May 13, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"CUe9760UorXWpASylLZmEYtfXBcflEbIVtbMYurzPknRsjISrWD4km","news_summary":"Nuvo Group Announces Partnership with Hadassah-Hebrew University Medical Center to Develop Innovative Pregnancy Population Management Platform","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"49a351dd-2ee1-4448-b92b-82344dc874a3","date":"Mar 30, 2020","link":"https://www.prnewswire.com/news-releases/nuvo-group-receives-fda-clearance-for-its-innovative-invu-remote-pregnancy-monitoring-system-301031716.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"remote monitoring, pregnancy care","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has received FDA clearance to market INVU, a remote monitoring platform for pregnancy care. The platform offers measurements of fetal and maternal heart rate through a wireless sensor band. Healthcare providers can now remotely obtain documentation of medical-grade heart rates. The INVU platform will be available by prescription from healthcare providers. The technology aims to provide safe and effective prenatal monitoring solutions remotely, especially during the COVID-19 pandemic. The companys mission is to advance pregnancy care with new technology and tools. Nuvo Group is committed to giving every life a better beginning.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["FDA clearance","INVU platform","remote monitoring","pregnancy care","COVID-19 pandemic"],"date_of_event":"March 30, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"xxFRIwmrzfExFzJO4IOrYTlutyzfSXUh5Pr8cod7BP9fSQHefhLgos","news_summary":"Nuvo Group Receives FDA Clearance for its Innovative INVU Remote Pregnancy Monitoring System","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"32b59eee-1ae3-4b65-96fc-1526ea26103d","date":"Sep 3, 2019","link":"https://www.businesswire.com/news/home/20190903005548/en/Nuvo-Group-Launches-Distinguished-Strategic-Advisory-Board","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"Jzj1zJksDJNtyfts0dRJPCnyKNYCXibPVbz4KU6Q0vpPTOT62F4EHI","news_summary":"Nuvo Group Launches a Distinguished Strategic Advisory Board to Address Key Innovations in Connected Pregnancy for Providers and Expectant Mothers","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"e6a854cd-d02b-4305-97d7-2b5f66970c81","date":"Aug 23, 2019","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3768498,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"pregnancy monitoring","company":"Nuvo Inc.","layoffs":null,"summary":"Tel Aviv-based startup Nuvo Inc. has developed a belt-like device called Invu that offers non-invasive fetal and maternal monitoring for pregnant women. The device measures indicators of fetal and maternal wellbeing using sensors and provides information directly to the patients phone and a comprehensive report to her physician. Nuvos business model is to charge insurers per report issued, with an estimated cost of $300 per pregnancy. The company has completed a clinical trial with 150 patients and is awaiting approval from the U.S. Food and Drug Administration (FDA). Nuvo expects to start shipping its product in early 2020 and has received letters of intent from one of Israels largest health maintenance organizations.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["pregnancy-related deaths","fetal and maternal monitoring","Nuvos device","clinical trial","regulatory approval"],"date_of_event":"2019-12-31","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"vIdgEyThjfVFpPJvcYROfauY2cumoBLbZUJ1klZXBaGSkik9QEgmCj","news_summary":"Israeli Startup Nuvo Develops a Home Fetal and Maternal Monitor for High-Risk Pregnancies","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"01c7685f-9442-4424-8e99-a8f8a2853924","date":"Apr 15, 2019","link":"https://officesnapshots.com/2019/04/15/nuvo-group-offices-tel-aviv/","source":"officesnapshots.com","visible":1,"analysis":{"tags":"office design","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group, a healthcare technology company, has opened new offices in Tel Aviv. The office design reflects the data-centered and feminine nature of the companys products and provides spaces for innovation. The 1,500 square meter office occupies an entire floor of the Alon Towers in Tel Avivs business center. The design includes a Research and Development HUB that accommodates the companys employees and labs. Custom multi-purpose furniture pieces were created to provide divisions between teams and integrated writing surfaces and storage. The design concept is inspired by the unique nature of the companys primary product, which is soft and feminine in design but based on complex data and technology.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["office design","healthcare technology","feminine nature","research and development","custom furniture"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"KYRlUPBEoikKogetNtFwMjSc93Gt0U9HKTeNQzkcGlc5PzdgKKA44m","news_summary":"Office Tour: Nuvo Group Offices - Tel Aviv","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"66a4de15-5935-4b14-8737-f280ab0b439a","date":"Mar 26, 2019","link":"https://www.prnewswire.com/news-releases/united-states-food-and-drug-administration-is-reviewing-nuvo-group-ltds-remote-monitoring-platform-300818222.html?tc=eml_cleartime","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"remote pregnancy monitoring","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has submitted the PregSense remote monitoring application to the FDA for De Novo classification. If granted clearance, the remote platform will be marketed as Invu by Nuvo. Invu is an investigational device designed for remote pregnancy monitoring, allowing non-invasive measurement of fetal and maternal heart rates. The submission is based on clinical and scientific validation, showing that Nuvos platform accurately extracts heart rates and offers real-time convenience. This regulatory milestone aligns with Nuvo Groups vision of advancing maternal-fetal connected health. The company aims to enable a connected pregnancy where visits are seamlessly connected across various settings. Nuvo Group is committed to transforming pregnancy care through proprietary software solutions and innovative product design.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["FDA clearance","remote pregnancy monitoring","connected pregnancy","De Novo classification","clinical validation"],"date_of_event":"March 26, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"LlDtSHb9ObCbR6lwEv8M7SLjCagotCDrr5X3CWzoe7kNCnyTFEqcbD","news_summary":"United States Food and Drug Administration is Reviewing Nuvo Group LTD's Remote Monitoring Platform","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"64a38ec3-3135-4ce8-aec6-a0df84990f8a","date":"Mar 18, 2019","link":"https://www.prnewswire.com/news-releases/nuvo-group-ltd-presents-data-on-remote-monitoring-in-pregnancy-at-the-66th-annual-society-for-reproductive-investigation-sri-meeting-300813907.html?tc=eml_cleartime","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"maternal-fetal health","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group presented positive results for its investigational remote monitoring technology at a scientific meeting. The study compared Nuvos Invu platform with the current standard of care, cardiotocographs (CTG), and showed that Invu could extract fetal and maternal heart rates comparable to CTG. The study also indicated that Invu has the potential to offer safe and accurate fetal and maternal monitoring in the comfort of a patients home. The partnership with various medical centers highlights the need for better pregnancy data and access to healthcare professionals. Nuvo Group aims to transform pregnancy care through innovative solutions and big data analytics.","partners":["Hadassah Medical Center","University Hospital in Heidelberg","The Perelman School of Medicine at the University of Pennsylvania","Eastern Virginia Medical School"],"customers":null,"investors":null,"confidence":8,"key_topics":["pregnancy data","remote monitoring technology","comparing Invu with CTG","positive results","improving maternal and fetal health"],"date_of_event":"March 18, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"NLfEna1OGiisow3NHcbZ9MBIzcFuR2NdH9yK5LnAmYa8ZviH00fQqP","news_summary":"Nuvo Group LTD Presents Data on Remote Monitoring in Pregnancy at the 66th Annual Society for Reproductive Investigation (SRI) Meeting","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ae400281-60cb-4df4-ab8d-83e443107492","date":"Nov 27, 2018","link":"https://www.prnewswire.com/news-releases/nuvo-group-enhances-commercialization-expertise-with-the-addition-of-consumer-products-industry-leader-deb-henretta-to-its-board-of-directors-300755896.html?tc=eml_cleartime","source":"www.prnewswire.com","visible":1,"analysis":{"tags":["digital business transformation","maternal-fetal health","commercialization","womens health"],"company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group, an emerging leader in maternal-fetal connected health, has appointed Deb Henretta to its Board of Directors. Henretta brings extensive commercialization experience and expertise in digital business transformation in the consumer product and wellness space. Nuvo Group aims to introduce new offerings to a new generation of physicians and parents to transform pregnancy care. Henrettas knowledge and leadership roles in commercializing products that support women and babies will be invaluable in guiding Nuvo Group. She has previously served in leadership positions at Procter & Gamble and currently serves on the Board of Directors at Corning Inc., Meritage Homes Corporation, and S.C. Johnson.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Deb Henretta","Board of Directors","maternal-fetal health","commercialization","womens health"],"date_of_event":"November 27, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"bQkyc4xBHC9oYxYKyNwlewGgHDliv2FatGGBX98BfIWa0X7INOJpkj","news_summary":"Nuvo Group Enhances Commercialization Expertise With The Addition Of Consumer Products Industry Leader Deb Henretta To Its Board Of Directors","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"dc6d898c-42c3-406c-a44d-dd710ed342c4","date":"Jul 11, 2018","link":"https://www.prnewswire.com/news-releases/nuvo-group-names-amit-reches-as-vice-president-ai-and-information-300679055.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"AI, maternal-fetal health","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has appointed Amit Reches as Vice President, AI and Information. Reches will lead the companys technological efforts in artificial intelligence in Nuvo Groups wearable monitoring technology, big data analytics, and cloud-based platform. The addition of Reches to the team will help Nuvo Group establish itself as a global leader in AI and maternal-fetal health. Reches previously served as Vice President of R&D at ElMindA ltd., where he led the commercialization of an AI-based platform. Nuvo Group is committed to transforming pregnancy care through proprietary software solutions and innovative product design that utilize big data analytics.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["AI","maternal-fetal health","wearable monitoring technology","big data analytics","cloud-based platform"],"date_of_event":"July 11, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Kn25PUd1PsdrLuZWT7AsvUzypdTOfNw0JQIC2faWerOnfb8AmHEyE5","news_summary":"Nuvo Group Names Amit Reches As Vice President, AI And Information","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7542440a-1f37-487a-969e-b1fab07a7871","date":"Jun 26, 2018","link":"http://markets.businessinsider.com/news/stocks/nuvo-group-raises-30-million-in-financing-led-by-shareholder-value-management-ag-1027316583","source":"markets.businessinsider.com","visible":1,"analysis":{"tags":"maternal-fetal connected health","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group, an emerging leader in maternal-fetal connected health, has raised $30 million in financing to accelerate the development of its innovative platform for pregnancy management. The financing was led by Shareholder Value Management AG, which has invested $13 million in the company. Nuvo Group aims to create technology-enabled solutions that use AI, Big Data, and machine learning in wearable devices for remote monitoring. The companys goal is to transform the experience of pregnancy by providing real-time information to mothers and physicians, enabling better management of the pregnancy while reducing costs to health systems. The financing will support the development of cutting-edge technologies and proprietary data and analytics platforms.","partners":null,"customers":null,"investors":"Shareholder Value Management AG","confidence":9,"key_topics":["Financing","Development","Pregnancy management","Wearable devices","Artificial Intelligence"],"date_of_event":"June 26, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$30 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"QbDCLX4pILkp6eM4RFbPbqNPAd7RUl2dKgnM1wdhU07YHw1QV8EP2f","news_summary":"Nuvo Group Raises $30 Million In Financing Led By Shareholder Value Management AG","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"e3fc6c1a-fc36-4e4b-b474-5c30cd29a6c9","date":"Jun 26, 2018","link":"http://nocamels.com/2018/06/maternal-fetal-health-company-nuvo-group-raises-30m/","source":"nocamels.com","visible":1,"analysis":{"tags":"wearable technology, pregnancy health","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group, a company that develops wearable technologies for pregnancy health, has raised $30 million in a new financing round led by Shareholder Value Management AG. The funding will be used to accelerate the development of Nuvos innovative platform, which aims to provide continuous, consistent, and connected care for expectant parents and healthcare professionals. Nuvo Groups wearable devices, incorporating Artificial Intelligence and Big Data, will enable expecting mothers to connect with their doctors throughout their pregnancy, allowing for better monitoring and informed decision-making. The companys initial product, Preg-Sense, is currently undergoing clinical investigation for FDA clearance.","partners":null,"customers":null,"investors":"Shareholder Value Management AG","confidence":9,"key_topics":["Financing round","Wearable technology","Pregnancy management","Artificial Intelligence","FDA clearance"],"date_of_event":"June 26, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$30 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"S0eZgQP04spihpX1jXSNeq8VHu8ibZ7roFHLIYYOzPqPlZflUNmuQv","news_summary":"Maternal-Fetal Health Company Nuvo Group Raises $30M","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"728ce38c-e32a-490d-baed-7e4590bd3188","date":"Apr 16, 2018","link":"https://www.massdevice.com/nuvo-launches-pivotal-trial-for-pregsense-home-maternity-monitor/","source":"www.massdevice.com","visible":1,"analysis":{"tags":"maternal fetal monitoring","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has launched a trial of its PregSense maternal fetal monitoring system to compare it against the current standard of care. The trial will assess the agreement between PregSense data collection and values measured by CTG prenatal monitoring. The company aims to challenge the status quo of pregnancy monitoring technology, which has remained largely unchanged for decades. The goal is to create a wireless wearable system that can record fetal and maternal parameters non-invasively and continuously, providing continuous, real-time access to information. The trial is expected to last up to two years.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["PregSense","maternal fetal monitoring","trial","wearable monitoring technology","continuous, real-time access to information"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"OAmIMRz15A7pouTwggJZFnSl7UGUkSXPSYlAB0ge9E6Jj814vwzUUd","news_summary":"Nuvo launches pivotal trial for PregSense home maternity monitor","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"eed614f5-ab2b-4a76-b9d8-d53452d3c2d4","date":"Apr 12, 2018","link":"https://www.prnewswire.com/news-releases/study-compares-new-pregnancy-monitoring-technology-with-decades-old-standard-of-care-300629053.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"maternal-fetal care","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has announced the start of a clinical trial to compare its PregSense maternal fetal monitoring system with the current standard of care. The trial will be conducted across four sites and involve up to 200 pregnant women. PregSense measures markers of fetal and maternal wellbeing using surface electrodes on the maternal abdomen. The company aims to provide continuous, real-time access to information for expectant parents and health professionals. PregSense is currently undergoing clinical investigation to support FDA clearance and is not yet available for sale in the United States.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["maternal-fetal monitoring","PregSense","clinical trial","wearable technology","pregnancy care"],"date_of_event":"April 12, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"k7E5W1NRLcZfGwXzyqpvaKdlmBX9tHNTDKlJg40HIpVJD8OmTmFErc","news_summary":"Study Compares New Pregnancy Monitoring Technology With Decades Old Standard Of Care","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"b795a5e2-4dbc-4003-9ad3-872c8a1de267","date":"Mar 22, 2018","link":"https://www.prnewswire.com/news-releases/nuvo-group-names-debra-bass-as-global-chief-marketing-officer-and-president-nuvo-group-america-300618394.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"maternal-fetal health","company":"Nuvo Group","layoffs":null,"summary":"Nuvo Group has named Debra Bass as Global Chief Marketing Officer and President, Nuvo Group America. Bass will lead the global development of the Nuvo Group brand and the U.S. market introduction of the companys wearable monitoring technologies for maternal-fetal care. The appointment is seen as a positive growth move for the company. Bass joins Nuvo Group from Johnson & Johnson, where she served as President of Global Marketing Services. Nuvo Group recently closed a $15 million financing round led by German institutional investors. The company aims to improve maternal-fetal care by providing continuous, remote, and hassle-free pregnancy monitoring.","partners":null,"customers":null,"investors":"German institutional investors advised by Shareholder Value Management AG","confidence":9,"key_topics":["Debra Bass","maternal-fetal health","wearable monitoring technologies","big data analytics","cloud-based platform"],"date_of_event":"March 22, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$15 million","structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"5fSeQXFZeIFP6TGSW9Ach2iCzGjpyMtrSdy3R23yZ7jBJOyHjGSCTe","news_summary":"Nuvo Group Names Debra Bass as Global Chief Marketing Officer and President, Nuvo Group America","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d5f374dd-d25c-4341-aa6b-1796c59b345f","date":"Jun 7, 2015","link":"http://www.haaretz.com/business/start-up-of-the-week/1.659959","source":"www.haaretz.com","visible":1,"analysis":{"tags":"wearable monitor","company":"Nuvo Group","layoffs":null,"summary":"Israeli medical experts have developed a wearable mobile monitor called PregSense, which provides data on the status of the fetus and the mothers health. The monitor has sensors woven into an elastic harness and a Bluetooth-enabled device that collects and transmits data to a smartphone. The data is stored on a secure cloud-based database accessible only to expectant mothers and their physicians. The Nuvo Group, led by Oren Oz, developed the device and plans to launch a consumer version called Ritmo Beats by the end of 2015. The device aims to provide reassurance to pregnant women and reduce dependency on doctors for monitoring. It also has the potential to detect symptoms that may lead to complications in pregnancy earlier.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["wearable monitor","pregnancy care","data collection","remote monitoring","cost reduction"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"F5c6jdyHeOF1bbhgtImpirM05nRQfUvofm6QUs5S882XoS1dyaPBR5","news_summary":"Israelis develop wearable device for non-stop fetal monitoring","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"1520a3fd-50e8-4601-aada-8cc1b65563e7","date":"Jun 1, 2015","link":"http://www.reuters.com/article/us-israel-mobile-foetus-monitor-idUSKBN0OH2NF20150601","source":"www.reuters.com","visible":1,"analysis":{"tags":["wearable monitor","pregnancy","healthcare"],"company":"Nuvo Group","layoffs":null,"summary":"Israeli medical experts have developed a wearable mobile monitor called PregSense, which provides data on the status of the fetus and the mothers health during pregnancy. The monitor has sensors woven into an elastic harness and a bluetooth-enabled device that collects and transmits data to a smartphone. The data is stored on a secure cloud-based database accessible to expectant mothers and their physicians. The device is developed by the Nuvo Group and is expected to change pregnancy care management and provide better care at a lower cost. The consumer version of the product, called Ritmo Beats, is set to launch by the end of 2015.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["wearable monitor","pregnancy","healthcare","data collection","remote monitoring"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"FajVlTKjRlmQMCMbK0XJ5NCa8DY1AqqGU6HQI24R4wOEzHNC8iA671","news_summary":"Wearable device provides continuous fetal monitoring","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":36,"techcommunityinvolvement":null,"mediagallery":[{"id":"783cb533-a27c-4cf7-be5a-5aec15e998ed","timestamp":"2019-04-18 09:09:47.000000","resources_type":1,"resources_title":"Invu2","resources_file_name":"$42pKxner540Z8dtnj5xh9uOzmxuryn9ResjmUzAAf3NgvxKgZoy2FD","alt":"Invu2 logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$42pKxner540Z8dtnj5xh9uOzmxuryn9ResjmUzAAf3NgvxKgZoy2FD","url":"https://storage.googleapis.com/clean-finder-353810/$42pKxner540Z8dtnj5xh9uOzmxuryn9ResjmUzAAf3NgvxKgZoy2FD"},{"id":"94a9ca1d-00ea-4cb7-9b7a-ef35f8756060","timestamp":"2019-04-18 09:08:23.000000","resources_type":1,"resources_title":"Invu","resources_file_name":"$swv1J4DBK0Wt4RVg9b5wNIpLKVh9y0QfNERWWyDI6nSFMB7YDyLfnq","alt":"Invu logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$swv1J4DBK0Wt4RVg9b5wNIpLKVh9y0QfNERWWyDI6nSFMB7YDyLfnq","url":"https://storage.googleapis.com/clean-finder-353810/$swv1J4DBK0Wt4RVg9b5wNIpLKVh9y0QfNERWWyDI6nSFMB7YDyLfnq"}],"tags":["femtech","sensors","remote-monitoring","prevention","non-invasive","babies","big-data","digital-healthcare","consumer-electronics","pregnancy","gynecology","telehealth","wearable","artificial-intelligence","machine-learning","mobile-applications","cloud-based","data-analytics","medical-data","cardiology","insurance-companies","healthcare-providers","mhealth","personalization","decision-support","women-health"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pv12fQLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4b8IDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgrgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B2C"],"productstage":"Released","products":["Invu"],"geomarkets":["United Kingdom","United States","Denmark","North America","Germany","Israel","Europe","Asia"],"targetmarkets":[],"marketcapital":5654455,"marketcapitaldate":"2025-01-17T14:00:10.000Z","funding":{"investors":5,"lastfunding":"Undisclosed","totalrounds":4,"fundingstage":"Public","totalfunding":"$58M","publicinvestors":5,"lastpublicfunding":0,"totalpublicrounds":4,"totalpublicfunding":58000000},"team":[{"name":"Rice  Powell","email":"","phone":"","gender":"Male","userid":"PtAdIYNZ50JLsGXIJieok0BzYzNSKyZx14mhR4t85zNHmaAVFaKHpS","bounced":false,"claimed":null,"founder":0,"urlname":"rice-powell","visible":1,"memberid":"JtzJSH7v9YNBmLTEaKBVqlXJh3OISYHgkBT5T4kGHxFe5qzsFyC2eg","position":"CEO","last_name":"Powell","claimtoken":"EQq1D6v4N31IE0BhRaCYgoLbYwtCwE8CHdT7NXUIOmxI5CpF3yZFvA","first_name":"Rice ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/rice-powell/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-11-18 14:35:06.000000","initials":"RP","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Oren Oz","email":"oren@nuvo-group.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGywIsIDA","bounced":false,"claimed":0,"founder":1,"urlname":"oren-oz-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg2ePJnAoM","position":"Founder (no longer with the company)","last_name":"Oz","claimtoken":"cy65VnZKBE2dWKZ5mINOLv5KY88niPFMNMKIZS2kC4T1Wuwp5VFnrD","first_name":"Oren","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/oren-oz-a580776/","unsubscribed":false,"is_activeuser":0,"additionalemail":"oren@nuvo-group.com","claimedemaildate":"2022-10-18 14:58:16.000000","initials":"OO","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Amit Reches","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoIODivwKDA","bounced":false,"claimed":0,"founder":0,"urlname":"amit-reches","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgo--1ogoM","position":"CTO","last_name":"Reches","claimtoken":"0AW974Qtapp3EJT4ff17naGzma8rwxIDaDJ9vCIgeC9Gl1JXfzWRFy","first_name":"Amit","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/amit-reches-6660261/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-11-18 14:28:28.000000","initials":"AR","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ryan  Kraudel","email":"","phone":"","gender":"Male","userid":"LGa9tLXbnCm3WWe976CtROFR1m3WXNyTrACpPnlTpgk0HE84078OKb","bounced":false,"claimed":null,"founder":0,"urlname":"ryan-kraudel","visible":1,"memberid":"WRCR6A58tHUY8ZI9tc6Y9ZoM0t91w5e5wAfAzPXvCKXSv8djF22eYu","position":"VP Marketing","last_name":"Kraudel","claimtoken":"fStTMzn5RAoDtrV25Od21mBRvmfxNDW2402ehHin10ZC42KUzt1t8U","first_name":"Ryan ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ryan-kraudel/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-11-18 14:35:10.000000","initials":"RK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Max Bernstein","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4L6ypc8KDA","bounced":false,"claimed":1,"founder":0,"urlname":"max-bernstein","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgnd_hwgsM","position":"Business Development Analyst","last_name":"Bernstein","claimtoken":"57ede1c274e792ae9410a48415b6634f8dbe3f59f7419e89a6957264758783eb","first_name":"Max","picturekey":"$9CB0Gj2JxGcKzZSs7SDyppPGU3vRgRsm8QATa6lgHVKuzePzuiIPTn","claimeddate":"2020-06-09","linkedinurl":"https://www.linkedin.com/in/max-bernstein","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-06-09 07:55:39.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$9CB0Gj2JxGcKzZSs7SDyppPGU3vRgRsm8QATa6lgHVKuzePzuiIPTn","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Nikki Fig","email":"nikki.fig@nuvo-group.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNnYwakJDA","bounced":false,"claimed":1,"founder":0,"urlname":"nikki-fig","visible":0,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICguZj5xAgM","position":"Marketing & Business Development Manager","last_name":"Fig","claimtoken":"51ee485d93692a516ae8069bff428ce92ef4aecbf1d27ef867ba1096de313efd","first_name":"Nikki","picturekey":"$WDdcarM4kzpWh5GwIjLmW30e8OfC5jc7LC4WJXzO53oSaNbIUsNYCD","claimeddate":"2018-06-18","linkedinurl":"https://www.linkedin.com/in/nikki-fig-722b4b11","unsubscribed":false,"is_activeuser":1,"additionalemail":"nikki.fig@nuvo-group.com","claimedemaildate":"2018-06-18 08:24:42.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$WDdcarM4kzpWh5GwIjLmW30e8OfC5jc7LC4WJXzO53oSaNbIUsNYCD","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>private</text>\n</div>'"}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPi8kYoKDA","fullname":"Ayelet Beazley"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":"2020-05-17T00:00:00.000Z","crunchbaseid":"nuvo-group","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":null,"creator_email":null,"createdate":"2014-10-29T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":"Ayelet Beazley","affiliatedOrganizations":null,"timeline":[{"id":"HlMsLjSDOMenY4KgFgQsf5QV1az4Q1Hg2bobuGfq1yRxR8AjIIkR3b","date":"May 2025","amount":"Undisclosed","source":"venture israel silent round","eventtype":"FundingRoundEvent","investment":[{"name":"VentureIsrael","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/ventureisrael","logokey":"$ocxblr2PqA5lDLCWlnjnxnTUwj6sZYfcP9pqojSbeFOe9Pn6LCjbNk","tagline":null,"urlname":"/investor_page/ventureisrael","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4K2S5dAKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"Ukj88gqFGffSMkBSzXK0esgb5Yk0CSXbBue8KBjvC2BUVo18iJsOTz","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ocxblr2PqA5lDLCWlnjnxnTUwj6sZYfcP9pqojSbeFOe9Pn6LCjbNk","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":""}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Public","fundingtypefundingtype":"PIPE","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"GtgWPgD9Nc02AaJYV6T8pZYP5dzdFLXxUXfIAOxHe8JfZyUngRSwCf","date":"May 2024","amount":"Undisclosed","source":"https://www.nuvocares.com/resources/remote-pregnancy-monitoring-company-nuvo-goes-public-through-merger-with-lamf-global-ventures","ticker":"NUVO","eventtype":"SpacEvent","valuation":"Undisclosed","investment":[],"capitalraised":"Undisclosed","stockexchange":"NASDAQ","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCIutD_CQw","acquiredcompany_spac":"LAMF Global Ventures I","stockexchange_logokey":"$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_spac_id":"X5V5hXtiXgp9TYXczBBUP3qRJR8AMi84YoLee46AuCYXjs7qUPlB6X","acquiredcompany_spac_type":"Investor","acquiredcompany_spac_hidden":true,"acquiredcompany_spac_fullurl":"/investor_page/lamf-global-ventures-i","acquiredcompany_spac_logokey":"$qOFPjfTaPTyIn421bqlmhLc6OTjXIt3BELw6ykVDiL9i1uuTRdR9b6.png","acquiredcompany_spac_urlname":"/investor_page/lamf-global-ventures-i","acquiredcompany_spac_homepage":"https://lamfglobal.com/","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_spac_logourl":"https://storage.googleapis.com/clean-finder-353810/$qOFPjfTaPTyIn421bqlmhLc6OTjXIt3BELw6ykVDiL9i1uuTRdR9b6.png","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":0,"valuationnumber":0},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCq3puaCQw","date":"May 2021","amount":"$10M","source":"https://www.klicapital.vc/portfolio","eventtype":"FundingRoundEvent","investment":[{"name":"Kli Capital","type":"Investor","amount":0,"hidden":false,"country":"Canada","fullurl":"/investor_page/kli-capital","logokey":"$KL0Llfx259qduejIotAP3m5TREa9DE37BzpFa3LGbSMDaKkicJtvXS","tagline":null,"urlname":"/investor_page/kli-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkJrZsq4JDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"485455a7-f8ae-4ee0-a38e-8ccb49bfc038","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$KL0Llfx259qduejIotAP3m5TREa9DE37BzpFa3LGbSMDaKkicJtvXS","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOC4jvymCAw","date":"Jun 2018","amount":"$48M","source":"Added by Max Bernstein","eventtype":"FundingRoundEvent","investment":[{"name":"GEM Capital","type":"Investor","amount":null,"hidden":false,"country":"Cyprus","fullurl":"/investor_page/gem-capital","logokey":"$yCLTRoqa4KRfeRuNVdRPkZa9z8ZFiJ21lXKFCmjXQTZ7iAMl4zrkjM","tagline":"","urlname":"/investor_page/gem-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJC4ycOTCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"LS84O23zpFJVTDzkQbCiL55HJUkW9XGfZMCkZoe1gQn8QOxhrovztg","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$yCLTRoqa4KRfeRuNVdRPkZa9z8ZFiJ21lXKFCmjXQTZ7iAMl4zrkjM","leadcaption":"","followupcaption":""},{"name":"Gal Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/gal-ventures","logokey":"$LasGcMKzLDqNeS0TT0K4BKRSw1u8rhyWnUF7n2GVcymF41HUB4KMoG","tagline":null,"urlname":"/investor_page/gal-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NXE49gJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"XNXFinvKG3UHCkVnjkZm4psrskFQuEYjggq3iqrNHNdvLIAHamxITX","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Private","leadpartnermemberid":null,"investmentVisibilityClassName":"private-visibility","investmentVisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$LasGcMKzLDqNeS0TT0K4BKRSw1u8rhyWnUF7n2GVcymF41HUB4KMoG","leadcaption":"","followupcaption":""},{"name":"Value Management AG","type":"Investor","amount":0,"hidden":false,"country":"Germany","fullurl":"/investor_page/value-management-ag","logokey":"$M6qXa1Fc5XYcONooeB1SnyVBtKl5oxLPyKfr3bJ3BD0SX9rSSUm0U5","tagline":"","urlname":"/investor_page/value-management-ag","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE7tOPCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"cXytJmU4LXaJrQs7e91EysU15rNDFMyZIpORPvgwiKU8ad9v2k4Sx1","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$M6qXa1Fc5XYcONooeB1SnyVBtKl5oxLPyKfr3bJ3BD0SX9rSSUm0U5","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":48000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"6/2007","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Nuvo ","logourl":"https://storage.googleapis.com/clean-finder-353810/$xnLAuhmmXBusBtOfoIhDGWOqyeTKz5BHC1d5qlaPRRaciz42mHHAxG","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$xnLAuhmmXBusBtOfoIhDGWOqyeTKz5BHC1d5qlaPRRaciz42mHHAxG","seoabout":"Nuvo is committed to reinventing pregnancy care through new technology, tools, and practices for providers and expectant mothers, including the INVU by Nuv...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":6,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Patient Remote Monitoring","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"Mobile","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgrgKDA","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Machine Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","classificationName":"coretechnology"},{"depth":1,"name":"Semiconductors & Electronics","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA","classificationName":"coretechnology"},{"depth":2,"name":"Wearables","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pv12fQLDA","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"},{"depth":1,"name":"Data Storage","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4b8IDA","classificationName":"coretechnology"},{"depth":2,"name":"Cloud","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgJDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Insurance Companies","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Women","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA","classificationName":"targetcustomer"},{"depth":3,"name":"Babies","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwLDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Patient Remote Monitoring#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","TechnologyClassificationModel>Semiconductors & Electronics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA>Wearables#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pv12fQLDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA>Women#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","TechnologyClassificationModel>Semiconductors & Electronics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA","TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Insurance Companies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA","TechnologyClassificationModel>Data Storage#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4b8IDA>Cloud#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","TechnologyClassificationModel>Data Storage#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4b8IDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA>Mobile#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgrgKDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA>Babies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwLDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA>Machine Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Patient Remote Monitoring#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Insurance Companies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|1:>IndustryClassificationModel/Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA|2:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA/Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA|3:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA/Women#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA|3:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA/Babies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwLDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA|2:>TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA/Mobile#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgrgKDA|1:>TechnologyClassificationModel/Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA|2:>TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA/Machine Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA|1:>TechnologyClassificationModel/Semiconductors & Electronics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA|2:>TechnologyClassificationModel>Semiconductors & Electronics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA/Wearables#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pv12fQLDA|1:>TechnologyClassificationModel/Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA|1:>TechnologyClassificationModel/Data Storage#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4b8IDA|2:>TechnologyClassificationModel>Data Storage#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4b8IDA/Cloud#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgJDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Digital Healthcare","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare","children":[{"title":"Patient Remote Monitoring","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Patient Remote Monitoring"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Patients","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"},{"title":"Insurance Companies","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Insurance Companies"},{"title":"Providers","key":"0-0-0-2","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]},{"title":"Consumers","key":"0-1","path":"IndustryClassificationModel>Consumers","children":[{"title":"Demographics & Family","key":"0-1-0","path":"IndustryClassificationModel>Consumers>Demographics & Family","children":[{"title":"Women","key":"0-1-0-0","path":"IndustryClassificationModel>Consumers>Demographics & Family>Women"},{"title":"Babies","key":"0-1-0-1","path":"IndustryClassificationModel>Consumers>Demographics & Family>Babies"}]}]}],"coreTechnology":[{"title":"Platforms & Interfaces","key":"0-0","path":"TechnologyClassificationModel>Platforms & Interfaces","children":[{"title":"Mobile","key":"0-0-0","path":"TechnologyClassificationModel>Platforms & Interfaces>Mobile"}]},{"title":"Artificial Intelligence","key":"0-1","path":"TechnologyClassificationModel>Artificial Intelligence","children":[{"title":"Machine Learning","key":"0-1-0","path":"TechnologyClassificationModel>Artificial Intelligence>Machine Learning"}]},{"title":"Semiconductors & Electronics","key":"0-2","path":"TechnologyClassificationModel>Semiconductors & Electronics","children":[{"title":"Wearables","key":"0-2-0","path":"TechnologyClassificationModel>Semiconductors & Electronics>Wearables"}]},{"title":"Sensing","key":"0-3","path":"TechnologyClassificationModel>Sensing"},{"title":"Data Storage","key":"0-4","path":"TechnologyClassificationModel>Data Storage","children":[{"title":"Cloud","key":"0-4-0","path":"TechnologyClassificationModel>Data Storage>Cloud"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Patient Remote Monitoring","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"Mobile","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgrgKDA","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Machine Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","classificationName":"coretechnology"},{"depth":1,"name":"Semiconductors & Electronics","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA","classificationName":"coretechnology"},{"depth":2,"name":"Wearables","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pv12fQLDA","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"},{"depth":1,"name":"Data Storage","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQ4b8IDA","classificationName":"coretechnology"},{"depth":2,"name":"Cloud","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgJDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Insurance Companies","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Women","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rOELDA","classificationName":"targetcustomer"},{"depth":3,"name":"Babies","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Digital Healthcare","Patient Remote Monitoring"],"coreTechnology":["Platforms & Interfaces","Mobile","Artificial Intelligence","Machine Learning","Semiconductors & Electronics","Wearables","Sensing","Data Storage","Cloud"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Patients","Insurance Companies","Providers","Consumers","Demographics & Family","Women","Babies"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"GtgWPgD9Nc02AaJYV6T8pZYP5dzdFLXxUXfIAOxHe8JfZyUngRSwCf","date":"May 2024","amount":"Undisclosed","source":"https://www.nuvocares.com/resources/remote-pregnancy-monitoring-company-nuvo-goes-public-through-merger-with-lamf-global-ventures","ticker":"NUVO","eventtype":"SpacEvent","valuation":"Undisclosed","investment":[],"capitalraised":"Undisclosed","stockexchange":"NASDAQ","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCIutD_CQw","acquiredcompany_spac":"LAMF Global Ventures I","stockexchange_logokey":"$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_spac_id":"X5V5hXtiXgp9TYXczBBUP3qRJR8AMi84YoLee46AuCYXjs7qUPlB6X","acquiredcompany_spac_type":"Investor","acquiredcompany_spac_hidden":true,"acquiredcompany_spac_fullurl":"/investor_page/lamf-global-ventures-i","acquiredcompany_spac_logokey":"$qOFPjfTaPTyIn421bqlmhLc6OTjXIt3BELw6ykVDiL9i1uuTRdR9b6.png","acquiredcompany_spac_urlname":"/investor_page/lamf-global-ventures-i","acquiredcompany_spac_homepage":"https://lamfglobal.com/","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_spac_logourl":"https://storage.googleapis.com/clean-finder-353810/$qOFPjfTaPTyIn421bqlmhLc6OTjXIt3BELw6ykVDiL9i1uuTRdR9b6.png","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":0,"valuationnumber":0}],"privateequityfunding":[{"id":"HlMsLjSDOMenY4KgFgQsf5QV1az4Q1Hg2bobuGfq1yRxR8AjIIkR3b","date":"May 2025","amount":"Undisclosed","source":"venture israel silent round","eventtype":"FundingRoundEvent","investment":[{"name":"VentureIsrael","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/ventureisrael","logokey":"$ocxblr2PqA5lDLCWlnjnxnTUwj6sZYfcP9pqojSbeFOe9Pn6LCjbNk","tagline":null,"urlname":"/investor_page/ventureisrael","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4K2S5dAKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"Ukj88gqFGffSMkBSzXK0esgb5Yk0CSXbBue8KBjvC2BUVo18iJsOTz","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ocxblr2PqA5lDLCWlnjnxnTUwj6sZYfcP9pqojSbeFOe9Pn6LCjbNk","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":""}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Public","fundingtypefundingtype":"PIPE","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCq3puaCQw","date":"May 2021","amount":"$10M","source":"https://www.klicapital.vc/portfolio","eventtype":"FundingRoundEvent","investment":[{"name":"Kli Capital","type":"Investor","amount":0,"hidden":false,"country":"Canada","fullurl":"/investor_page/kli-capital","logokey":"$KL0Llfx259qduejIotAP3m5TREa9DE37BzpFa3LGbSMDaKkicJtvXS","tagline":null,"urlname":"/investor_page/kli-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkJrZsq4JDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"485455a7-f8ae-4ee0-a38e-8ccb49bfc038","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$KL0Llfx259qduejIotAP3m5TREa9DE37BzpFa3LGbSMDaKkicJtvXS","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOC4jvymCAw","date":"Jun 2018","amount":"$48M","source":"Added by Max Bernstein","eventtype":"FundingRoundEvent","investment":[{"name":"GEM Capital","type":"Investor","amount":null,"hidden":false,"country":"Cyprus","fullurl":"/investor_page/gem-capital","logokey":"$yCLTRoqa4KRfeRuNVdRPkZa9z8ZFiJ21lXKFCmjXQTZ7iAMl4zrkjM","tagline":"","urlname":"/investor_page/gem-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJC4ycOTCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"LS84O23zpFJVTDzkQbCiL55HJUkW9XGfZMCkZoe1gQn8QOxhrovztg","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$yCLTRoqa4KRfeRuNVdRPkZa9z8ZFiJ21lXKFCmjXQTZ7iAMl4zrkjM","leadcaption":"","followupcaption":""},{"name":"Gal Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/gal-ventures","logokey":"$LasGcMKzLDqNeS0TT0K4BKRSw1u8rhyWnUF7n2GVcymF41HUB4KMoG","tagline":null,"urlname":"/investor_page/gal-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NXE49gJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"XNXFinvKG3UHCkVnjkZm4psrskFQuEYjggq3iqrNHNdvLIAHamxITX","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Private","leadpartnermemberid":null,"investmentVisibilityClassName":"private-visibility","investmentVisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$LasGcMKzLDqNeS0TT0K4BKRSw1u8rhyWnUF7n2GVcymF41HUB4KMoG","leadcaption":"","followupcaption":""},{"name":"Value Management AG","type":"Investor","amount":0,"hidden":false,"country":"Germany","fullurl":"/investor_page/value-management-ag","logokey":"$M6qXa1Fc5XYcONooeB1SnyVBtKl5oxLPyKfr3bJ3BD0SX9rSSUm0U5","tagline":"","urlname":"/investor_page/value-management-ag","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE7tOPCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"cXytJmU4LXaJrQs7e91EysU15rNDFMyZIpORPvgwiKU8ad9v2k4Sx1","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$M6qXa1Fc5XYcONooeB1SnyVBtKl5oxLPyKfr3bJ3BD0SX9rSSUm0U5","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":48000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}